BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30683899)

  • 1. Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair.
    van de Vrugt HJ; Harmsen T; Riepsaame J; Alexantya G; van Mil SE; de Vries Y; Bin Ali R; Huijbers IJ; Dorsman JC; Wolthuis RMF; Te Riele H
    Sci Rep; 2019 Jan; 9(1):768. PubMed ID: 30683899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
    Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
    Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells.
    Skvarova Kramarzova K; Osborn MJ; Webber BR; DeFeo AP; McElroy AN; Kim CJ; Tolar J
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28613254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
    Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
    DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 genome editing in human cells occurs via the Fanconi anemia pathway.
    Richardson CD; Kazane KR; Feng SJ; Zelin E; Bray NL; Schäfer AJ; Floor SN; Corn JE
    Nat Genet; 2018 Aug; 50(8):1132-1139. PubMed ID: 30054595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
    Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
    Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations.
    Tryon R; Zierhut H; MacMillan ML; Wagner JE
    Am J Med Genet A; 2017 Jan; 173(1):260-263. PubMed ID: 27714961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells.
    Siegner SM; Ugalde L; Clemens A; Garcia-Garcia L; Bueren JA; Rio P; Karasu ME; Corn JE
    Nat Commun; 2022 Nov; 13(1):6900. PubMed ID: 36371486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic
    Lach FP; Singh S; Rickman KA; Ruiz PD; Noonan RJ; Hymes KB; DeLacure MD; Kennedy JA; Chandrasekharappa SC; Smogorzewska A
    Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33172906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders.
    Ugalde L; Fañanas S; Torres R; Quintana-Bustamante O; Río P
    Cytotherapy; 2023 Mar; 25(3):277-285. PubMed ID: 36610813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Gene Therapy for Fanconi Anemia.
    Río P; Navarro S; Bueren JA
    Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotency and Gene Editing in Fanconi Anemia.
    Navarro S; Giorgetti A; Raya A; Tolar J
    Curr Gene Ther; 2017; 16(5):321-328. PubMed ID: 28103772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
    Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
    Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48.
    Velimezi G; Robinson-Garcia L; Muñoz-Martínez F; Wiegant WW; Ferreira da Silva J; Owusu M; Moder M; Wiedner M; Rosenthal SB; Fisch KM; Moffat J; Menche J; van Attikum H; Jackson SP; Loizou JI
    Nat Commun; 2018 Jun; 9(1):2280. PubMed ID: 29891926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of Fanconi Anemia Mutations Using Digital Genome Engineering.
    Sipe CJ; Kluesner MG; Bingea SP; Lahr WS; Andrew AA; Wang M; DeFeo AP; Hinkel TL; Laoharawee K; Wagner JE; MacMillan ML; Vercellotti GM; Tolar J; Osborn MJ; McIvor RS; Webber BR; Moriarity BS
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia.
    Behera CK; Gyandeep G; Mishra R; Mohanty RP; Pal A; Behera J; Samal S; Das B
    Mol Biol Rep; 2023 Jan; 50(1):931-936. PubMed ID: 36369330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted gene therapy and cell reprogramming in Fanconi anemia.
    Rio P; Baños R; Lombardo A; Quintana-Bustamante O; Alvarez L; Garate Z; Genovese P; Almarza E; Valeri A; Díez B; Navarro S; Torres Y; Trujillo JP; Murillas R; Segovia JC; Samper E; Surralles J; Gregory PD; Holmes MC; Naldini L; Bueren JA
    EMBO Mol Med; 2014 Jun; 6(6):835-48. PubMed ID: 24859981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.